Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis

Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 102 citations, 2008 year and closed oa status.